Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Neoplasm × Vinorelbine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 69 Carcinoma, Non-Small-Cell Lung 57 Lung Neoplasms 30 Hodgkin Disease 13 Lymphoma 11 Neoplasm Metastasis 8 Lymphoma, Non-Hodgkin 8 Recurrence 7 Prostatic Neoplasms 7 Neoplasms 7 Uterine Cervical Neoplasms 5 Adenocarcinoma of Lung 5 Sarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Mesothelioma, Malignant 4 Lymphoma, Large B-Cell, Diffuse 4 Breast Neoplasms, Male 4 Triple Negative Breast Neoplasms 3 Small Cell Lung Carcinoma 3 Ovarian Neoplasms 3 Multiple Myeloma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia 3 Burkitt Lymphoma 3 Waldenstrom Macroglobulinemia 2 Unspecified Adult Solid Tumor, Protocol Specific 2

Interventions

Vinorelbine 1 Interferon alpha-2 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00908869 2012-01-30

METRO1

Institut Paoli-Calmettes

Phase 1 Completed

Advanced Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡